Ignite Creation Date:
2024-05-05 @ 5:05 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00386321
Status:
TERMINATED
Last Update Posted:
2010-11-18
First Post:
2006-10-10
Brief Title:
Yt90 Zevalin and Combination Chemotherapy Z-CHOPin Treating Patients With Stage II Stage III or Stage IV Diffuse Large B-cell Lymphoma
Sponsor:
Chulalongkorn University
Organization:
Chulalongkorn University
Organization Data
Organization:
Chulalongkorn University
Class:
OTHER
Study ID:
TH011103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chulalongkorn University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bayer | INDUSTRY |